Solid Phase Extraction Using Modified Magnetic Iron Oxide Nanoparticles for Extraction and Spectrofluorimetric Determination of Carvedilol in Human Plasma Samples

Document Type : Research Article

Authors

1 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, I.R. IRAN+/Department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz. I.R. IRAN

2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, I.R. IRAN

Abstract

A new analytical approach was developed involving magnetic solid–phase extraction and spectrofluorimetric determination of carvedilol in human plasma samples. A plasma sample was prepared and adjusted to pH 8.2–10, then carvedilol was quickly extracted using iron oxide magnetic nanoparticles modified by the surfactant cetyltrimethylammonium bromide and determined to apply spectrofluorimetry at 354 ± 3 nm after excitation at 241 ± 3 nm. Experimental conditions, such as the amount of nanoparticles and cetyltrimethylammonium bromide, pH value, standing time and desorption solvent type and volume have been adjusted to optimize the extraction process and to obtain analytical characteristics of the method. Linearity was observed in the analyte concentration range of 2.0–125 ng/mL with correlation coefficients (r) of 0.999.
The method showed good precision and accuracy, with intra– and inter–assay precisions of less than 7.0% at all concentrations. Standard addition recovery tests were carried out, and the recoveries ranged from 94.4% to 100.7%. The limits of detection and quantification were found to be 0.67 and 2.24 ng/mL. The method was applied to the determination of carvedilol in human plasma samples. 

Keywords

Main Subjects

References

1] Biparva P., Abedirad  S.M., Kazemi, S.Y., ZnO Nanoparticles as an Oxidase Mimic-Mediated Flow-Injection Chemiluminescence System for Sensitive Determination of Carvedilol, Talanta, 130: 116–121 (2014).
[2] Jiang J., Tian L., Huang Y., Yan Y., Li Y., Enantioselective and Sensitive Determination of Carvedilol in Human Plasma Using Chiral Stationary-Phase Column and Reverse-Phase Liquid Chromatography with Tandem Mass Spectrometry, J. Chromatogr. B, 960: 92–97 (2014).
[3] Makahleh A., Yap H.F., Saad B., Vortex-Assisted Liquid-Liquid-Liquid Microextraction (VALLLME) Technique: A New Microextraction Approach for Direct Liquid Chromatography and Capillary Electrophoresis Analysis, Talanta, 43: 394–401 (2015).
[4] Magiera S., Baranowska I., A New and Fast Strategy Based on Semiautomatic Microextraction by Packed Sorbent Followed by Ultra High Performance Liquid Chromatography for the Analysis of Drugs and Their Metabolites in Human Urine, J. Sep. Sci., 37(22): 3314-3315 (2014).
[5] Magiera S., Adolf W., Baranowska I., Simultaneous Chiral Separation and Determination of Carvedilol and 5′-Hydroxyphenyl Carvedilol Enantiomers from Human Urine by High Performance Liquid Chromatography Coupled with Fluorescent Detection, Cent. Eur. J. Chem., 11(12): 2076-2087 (2013).
[6] Patel D.P., Sharma P., Sanyal M., Singhal P., Shrivastav P.S., UPLC-MS/MS Assay for the Simultaneous Quantification of Carvedilol and its Active Metabolite 4′Hhydroxyphenyl Carvedilol in Human Plasma to Support a Bioequivalence Study in Healthy Volunteers, Biomed. Chromatogr., 27(8): 974-986 (2013).
[7]  Azodi-Deilami S., Abdouss M., Asadi E., Najafabadi A.H., Sadeghi S., Farzaneh S., Asadi S., Magnetic Molecularly Imprinted Polymer Nanoparticles Coupled with High Performance Liquid Chromatography for Solid-Phase Extraction of Carvedilol in Serum Samples, J. Appl. Polym. Sci., 131 (23): 1-10 (2014).
[8] Boyaci E., Gorynski K., Rodriguez-Lafuente A., Bojko B., Pawliszyn J., Introduction of Solid-Phase Microextraction as a High-Throughput Sample Preparation Tool in Laboratory Analysis of Prohibited Substances, Anal. Chim. Acta, 809: 69–81 (2014).
[9] Adib N., Shekarchi M., A New HPLC Method for Determination of Carvedilol in Human Plasma and its Application in Bioequivalence Studies, Biosci. Biotech. Res. Asia, 12(1): 387-391 (2015).
[10] Shang J., He X., Xi C., Tang B., Wang G., Chen D., Peng T., Mu Z., Determination of the Potential illegal Addition of β-blockers to Function Foods by QuEChERS Sample Preparation and UPLC-MS/MS Analysis, Food. Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess, 32(7): 1040-1048 (2015).
[11] Jiang  J., Tian L., Huang Y., Yan Y., Li, Y., Enantioselective and Sensitive Determination of Carvedilol in Human Plasma Using Chiral Stationary-Phase Column and Reverse-Phase Liquid Chromatography with Tandem Mass Spectrometry, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 960: 92-97 (2014).
[12] El-Didamony A.M., Hafeez S.M., Saad, A.A., Extraction-Spectrophotometric Determination of Some Antihypertensive Drugs in Pharmaceutical and Biological Fluids Using two Sulphonphthalein Dyes, Int. J. Appl. Pharm., 7(1): 10-17 (2015).
[13] Fazeli-Bakhtiyari R., Sorouraddin M.H., Farajzadeh M.A., Somi M.H., Jouyban A., Salt-Assisted LLE Combined with Field-Amplified Sample Stacking in CE for Improved Determination of beta Blocker Drugs in Human Urine, Bioanalysis, 6(3): 319-34 (2014).
[14] Hamidi S., Soltani S., Jouyban A., A Dispersive Liquid–Liquid Microextraction and Chiral Separation of Carvedilol in Human Plasma Using Capillary Electrophoresis, Bioanalysis, 7(9): 1107-1117 (2015).
[15] Jouyban A., Sorouraddin M.H., Farajzadeh M.A., Somi M.H., Fazeli-Bakhtiyari R., Determination of Five Antiarrhythmic Drugs in Human Plasma by Dispersive Liquid-Liquid Microextraction and High-Performance Liquid Chromatography, Talanta, 134: 681–689 (2015).
[16] Soltani S., Ramezani A.M., Soltani N., Jouyban A., Analysis of Losartan and Carvedilol in Urine and Plasma Samples Using a Dispersive Liquid-Liquid Microextraction Isocratic HPLC-UV Method, Bioanalysis, 4(23): 2805-21 (2012).
[17] Zamani-Kalajahi M., Fazeli-Bakhtiyari R., Amiri M., Golmohammadi A., Afrasiabi A., Khoubnasabjafari M., Jouyban A., Dispersive Liquid-Liquid Microextraction Based on Solidification of Floating Organic Droplet Followed by Spectrofluorimetry for Determination of Carvedilol in Human Plasma, Bioanalysis, 5(4): 437-48 (2013).
[18] Zeeb M., Mirza B., Ionic Liquid Phase Microextraction Combined with Fluorescence Spectrometry for Preconcentration and Quantitation of Carvedilol in Pharmaceutical Preparations and Biological Media, DARU J. Pharm. Sci., 23(1): 30 (2015).
[19]  Wu H.,  Zhang L., Gao N.,  Li Y.,  Wang H., Liu Y.,  Tian L.,  Du L.M., Magnetic Retrieval of Ionic Liquids: High Sensitivity Fluorescence Determination of Carvedilol in Tablets, Plasma, and Urine, Anal. Lett., 49(2): 319-330 (2016).
[20] Talebpoura Z., Taraji M., Adib N., Stir Bar Sorptive Extraction and High Performance Liquid Chromatographic Determination of Carvedilol in Human Serum Using Two Different Polymeric Phases and an Ionic Liquid as Desorption Solvent, J. Chromatogr. A, 1236: 1– 6 (2012).
[21] Jouyban A., Sorouraddin M.H., Farajzadeh M.A., Somi M.H., Fazeli-Bakhtiyari R., Vortex-Assisted Liquid-Liquid Extraction Combined with Field-Amplified Sample Injection and Sweeping Micellar Electrokinetic Chromatography for Improved Determination of β-blockers in Human Urine, Talanta, 149: 298-309 (2016).
[22] Shariati-Rad M., Irandoust M., Sheikhi S., Development of a Highly Sensitive and Selective spectrophotometric Method for the Determination of Carvedilol in Pharmaceutical and Urine Samples, RSC Advances, 4(77): 40816-40823 (2014).
[23] Soleymanpour A., Ghasemian M., Chemically Modified Carbon Paste Sensor for the Potentiometric Determination of Carvedilol in Pharmaceutical and Biological Media, Measurement: J. Int. Meas. Conf., 59: 14-20 (2015).
[24] Sun L., Chen L., Sun X., Du X., Yue Y., He D., Xu H., Zeng Q., Wang H., Ding L., Analysis of Sulfonamides in Environmental Water Samples Based on Magnetic Mixed Hemimicelles Solid–Phase Extraction Coupled with HPLC–UV Detection, Chemosphere, 77: 1306–1312 (2009).
[25] Bagheri H., Zandi O., Aghakhani A., Extraction of Fluoxetine from Aquatic and Urine Samples Using Sodium Dodecyl Sulfate–Coated Iron Oxide Magnetic Nanoparticles Followed by Spectrofluorimetric Determination, Anal. Chim. Acta, 716: 61– 65 (2012).
[26] Zhao X., Shi Y., Cai Y., Mou S., Cetyltrimethylammonia bromide–Coated Magnetic Nanoparticles for the Preconcentration of Phenolic Compounds from Environmental Water Samples, Environ. Sci. Technol., 42: 1201–1206 (2008).
[27] Zhao X., Shi Y., Wang T., Cai Y., Jiang G., Preparation of Silica–Magnetic Nanoparticle Mixed Hemimicelle Sorbents for Extraction of Several Typical Phenolic Compounds from Environmental Water Samples, J. Chromatogr. A, 1188: 140–147 (2008).
[28] Tavakoli M., Shemirani F., Hajimahmoodi M., Magnetic Mixed Hemimicelles Solid–Phase Extraction of Three Food Colorants from Real Samples, Food Anal. Method, 7: 100–108 (2014).
[29] Sun L., Zhang C., Chen. L., Liu J., Jin H., Xu H., Ding L., Preparation of Alumina–Coated Magnetic Nanoparticle for Extraction of Trimethoprim from Environmental Water Samples Based on Mixed Hemimicellessolid–Phase Extraction, Anal. Chim. Acta, 638: 162–168(2009).
[30] Khoeini Sharifabadi M., Saber Tehrani M., Mehdinia A., Abroomand Azar P., Waqif Husain S., Fast Removal of Citalopram Drug from Waste water Using Magnetic Nanoparticles Modified with Sodium Dodecyl Sulfate Followed by UV–Spectrometry, J. Chem. Health Risk., 3: 35–41(2013).
[31] Ibarra Israel S., Rodriguez Jose A., Galán-Vidal Carlos A., Cepeda A., Miranda Jose M., Magnetic Solid Phase Extraction Applied to Food Analysis, J. Chem., 2015: Article ID 919414 (2015).
[32] Chen L., Wang T., Tong J., Application of Derivatized Magnetic Materials to the Separation and the Preconcentration of Pollutants in Water Samples, TrAC Tren. Anal. Chem., 30: 1095–1108 (2011).
[33] Ahmadi S. H., Davar P., Manbohi A., Adsorptive Removal of Reactive Orange 122 from Aqueous Solutions by Ionic Liquid coated Fe3O4 Magnetic Nanoparticles as an Efficient Adsorbent, Iran. J. Chem. Chem. Eng. (IJCCE), 35(1): 63-73 (2016).
[34] Wang L., Yuan Q., Liang G., Shi L., Zhan Q., Magnetic Mixed Hemimicelles Solid-Phase Extraction Coupled with High-Performance Liquid Chromatography for the Extraction and Rapid Determination of Six Fluoroquinolones in Environmental Water Samples, J. Sep. Sci., 38: 996–1001 (2015).
[35] Ramandi N. F., Shemirani F., Surfacted Ferrofluid Based Dispersive Solid Phase Extraction; a Novel Approach to Preconcentration of Cationic Dye in Shrimp and Water Samples, Food Chem., 185: 398–404 (2015).
[36] Bavili Tabrizi A., Rashidi M. R., Ostadi H., A Nanoparticle–Based Solid–Phase Extraction Procedure Followed by Spectrofluorimetry to Determine Carbaryl in Different Water Samples, J. Braz. Chem. Soc., 25: 709–715 (2014).
[37] Bavili Tabrizi A., Sepehr B., Extraction of Ammonia and Nitrite Using Modified Magnetic Iron Oxide Nanoparticles before Spectrophotometric Determination in Different Water Samples, Int. J. Environ. An. Ch., 95(9): 833-846 (2015).
[38] Poursaberi  T., Akbar V.,  Shoja S.M.R., Application of Rh(III)-Metalloporphyrin Grafted Fe3O4 Nanoparticles for the Extraction of Thiocyanate Ions from Aqueous Solutions, Iran. J. Chem. Chem. Eng. (IJCCE), 34: 41-49 (2015).
[39] Sadeghi S., Azhdari H., Arabi H., Moghaddam Zeraatkar A., Surface Modified Magnetic Fe3O4 Nanoparticles as a Selective Sorbent for Solid Phase Extraction of Uranyl Ions from Water Samples, J. Hazard.Mater., 215–216: 208–216 (2012).
[40] Karimi M.A., Hatefi–Mehrjardi A., Mohadesi A., Mohammadi S.Z.,  Taghdiri M., Yarahmadi J., Mahmoodian H., Nezhad Khorasani S., Solid Phase Extraction–Spectrophotometric Determination of Phosphate Using Modified Magnetic Nanoparticles asEextractor, Iran. J. Anal. Chem., 1: 7–11 (2014).
[41] Faraji M., Yamini Y., Rezaee M., Extraction of Trace Amounts of Mercury with Sodium Dodecyle Sulphate–Coated Magnetic Nanoparticles and its Determination by Flow Injection Inductively Coupled Plasma–Optical Emission Spectrometry, Talanta, 81: 831–836 (2010).
[42] Bavili Tabrizi A., Naini S., Parnian K., Mohammadi S., Emami zad F., Pourtaghi Anvarian S., Abdollahi A., Determination of Triamterene in Human Plasma and Urine after its Cloud Point Extraction, Quim. Nova, 37(7):1182–1187 (2014).
[43] US DHHS, FDA and CDER, Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for Veterinary Medicine, 2001, Available at:
       http://www/fda.gov/cder/guidance/index.htm(accessed on March 6, 2009).
[44] Lamprecht G., Stoschitzky K., Determination of Carvedilol in Human Plasma by High-Performance Liquid Chromatography Applying On-line Deproteination and Column Switching, Chromatographia, 59: 551–554 (2004).
[45] Furlong M. T., He B., Mylott W., Zhao S., Mariannino T., Shen J., Stouffer B., A Validated Enantioselective LC–MS/MS Assay for the Simultaneous Determination of Carvedilol and its Pharmacologically Active 4-Hydroxyphenyl Metabolite in Human Plasma: Application to a Clinical Pharmacokinetic Study, J. Pharmaceut. Biomed. Anal., 70: 574–579 (2012).

Files

Share

How to cite

Statistics